apollo

Select Address

0
  • Login

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT

About

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT belongs to the class of medicines called ‘immunizing agents’. It is given to individuals aged nine to twenty-six years to prevent various diseases caused by Human Papillomavirus (HPV). Human papillomavirus (HPV) can cause genital warts, cancer of the cervix, anal cancer, and various cancers of the vulva or vagina.

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is a quadrivalent vaccine or immunizing agent which is made from a live and weakened or attenuated virus (mixture of virus-like particles derived from the L1 capsid proteins of HPV types 6, 11, 16 and 18). It helps develop immunity by stimulating the immune system to produce relevant antibodies. It is essential to take the vaccine doses as per the doctor’s advice to develop protection against the diseases.

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT will be administered by a healthcare professional. In a few cases, HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may cause side-effects such as fever, nausea, headache, redness, pain, and swelling at the injection site. These side-effects are temporary and resolve without any treatment. However, inform your doctor immediately if any of these side effects persist or get worse.  

Before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT, please notify your doctor if you are allergic to any medications. Inform your doctor if you have any allergies, a weakened immune system resulting from long-term diseases such as genetic disease, HIV, or cancer, a serious infection or illness with fever, a bleeding disorder, or immunological diseases before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. Let your doctor know if you are pregnant, think you may be pregnant or plan to have a baby or breastfeed. Keep your doctor informed about your health condition and all the medicines you take before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT to rule out any side effects.

Uses of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT

Prevention of Human papillomavirus (HPV)-associated cancers

Medicinal Benefits

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is used to prevent Human papillomavirus (HPV)-associated cancers. It helps develop immunity by stimulating the immune system to produce antibodies against the Human papillomavirus that causes genital warts, cancer of the cervix, anal cancer, and various cancers of the vulva or vagina.

Directions for Use

HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT will be administered by a qualified healthcare professional. Kindly do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT

  • Injection site redness
  • Injection site pain
  • Injection site swelling
  • Fever
  • Nausea
  • Headache

In-Depth Precautions and Warning

Drug Warnings

Before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT, please notify your doctor if you have allergic reactions after a previous dose of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT or yeast (a vaccine component). Individuals who develop hypersensitivity symptoms after receiving a dose of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT should not receive any additional doses. Inform your doctor if you have any allergies, a weakened immune system resulting from long-term diseases such as genetic disease, HIV, or cancer, a serious infection or illness with fever, a bleeding disorder (bleed more than usual), or immunological diseases before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. Inform your doctor if you are pregnant or breastfeeding, think you may be pregnant or plan to have a baby. Keep your doctor informed about your health condition and all the medicines you take before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT to rule out any side effects.

Drug Interactions

Drug-Drug Interactions: HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may interact with substances or medications that suppress the immune system (e.g. mycophenolate mofetil, hydroxychloroquine, azathioprine).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT should not be used in individuals with a weak immune system, blood disorders, infections, immunological diseases, and severe illness with fever.

Drug-Drug Interactions Checker List:

  • MYCOPHENOLATE MOFETIL
  • HYDROXYCHLOROQUINE
  • AZATHIOPRINE
  • Safety Advice

    • Safety Warning

      Alcohol

      caution

      It is unknown whether it is safe to consume alcohol with HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. However, it is advisable not to take or limit alcohol as a precautionary measure.

    • Safety Warning

      Pregnancy

      caution

      Please consult the doctor. There are no adequate and well-controlled studies on pregnant women. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Breast Feeding

      caution

      Consult your doctor as there is no substantial research yet on the use of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT in breastfeeding/nursing mothers. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Driving

      safe if prescribed

      HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may not affect your ability to drive.

    • Safety Warning

      Liver

      safe if prescribed

      HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is probably safe when used in patients with liver diseases. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Kidney

      safe if prescribed

      HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is probably safe when used in patients with kidney diseases. Your doctor will prescribe only if the benefits outweigh the risks.

    • Safety Warning

      Children

      caution

      HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT should not be used in children under nine years.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Consume a healthy diet rich in fruits, vegetables, whole grains, and lean proteins. Avoid processed and refined foods.
    • Foods rich in vitamin C such as tomatoes, strawberries, and citrus fruits help to improve immunity. 
    • Limit dairy products such as milk and cheese.
    • Limit alcohol and caffeine intake and quit smoking.
    • Take adequate bed rest.
    • Drink a lot of water. Staying hydrated is essential both before and after your vaccination.
    • Eat a well-balanced diet. A well-balanced diet is essential.

    Special Advise

    Vaccines may develop syncope (temporary loss of consciousness), which can result in a fall with injury; therefore, observation for 15 minutes after administration is advised.

    Patients Concern

    Disease/Condition Glossary

    Cancer: Cancer is a disease that is caused by the uncontrolled division of abnormal cells in a specific part of the body.

    Genital warts:  It is a common sexually transmitted infection (HPV). Symptoms include the development of small growths/bumps on the genital areas.

    Cervical cancer: Cervical cancer, also known as cervix cancer, is a type of cancer that develops in the cells of the cervix. The sexually transmitted human papillomavirus is responsible for the majority of cervical cancer cases (HPV).

    Anal cancer: Anal cancer is defined as abnormal cell growth in or around the anus or anal canal. The majority of anal cancers are caused by human papillomavirus (HPV) infection.

    FAQs

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT belongs to the class of medicines called immunizing agents. It is given to individuals aged nine to twenty-six years to prevent various diseases caused by Human Papillomavirus (HPV).

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT helps develop immunity by stimulating the immune system to produce relevant antibodies against the Human papillomavirus (HPV).

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may result in side effects such as injection site redness, pain, swelling, fever, nausea, and headache. These side effects usually go away on their own. However, if any of these side effects persist or worsen, contact your doctor right away.

    The HPV quadrivalent vaccine is administered by the healthcare professional in three doses. You can get your first shot whenever you want as long as you're between the ages of 9 and 26. Then you'll need to get a second dose two months after your first shot and a third dose six months later.

    There are no adequate and well-controlled studies on pregnant and nursing women. Inform your doctor before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. If you are pregnant or breastfeeding, think you may be pregnant or plan to have a baby. Your doctor will prescribe only if the benefits outweigh the risks.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT should not be used in individuals with a weak immune system due to diseases (cancer or HIV) or medicines (immune suppressants), blood disorders, immunological diseases, and severe illness with fever.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is a vaccine that helps protect against human papillomavirus (HPV)-associated cancers.

    No, HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may not be effective against all types of human papillomavirus (HPV). The quadrivalent vaccine protects against HPV types 6, 11, 16, and 18.

    Individuals aged nine to twenty-six years can get vaccinated with HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT to prevent human papillomavirus (HPV)-associated cancers.

    Yes, you can have HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT even though you are not a virgin anymore. HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT will be effective even though you are sexually active and protect against HPV you haven’t been exposed to. However, it does not protect against HPV infections you already have.

    You may not need to start over again. However, please consult the doctor if you didn't get the last dose of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT.

    As the effect of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT works against most but not all HPV, you will still need to get a Pap smear test (a method of cervical screening).

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT works very well. It is highly immunogenic and effective in preventing HPV-related diseases.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT does not carry any health risks as it is safe and well-tolerated. In some cases, it may cause side effects like nausea, dizziness, fever, and injection-site reactions like pain, redness, swelling, itching, and bruising.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is a quadrivalent vaccine or immunising agent which is made from a live and weakened or attenuated virus.

    Yes, HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT can be given with other vaccines. However, let the doctor know that you have been vaccinated with HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT before getting other vaccinations.

    The protection with HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT lasts for a long time. Individuals who received HPV vaccinations showed no signs of a decrease in protection against the virus for at least 12 years.

    Though using a condom in the right way will lower the risk of HPV, it may not provide full protection as HPV can affect the areas the condom does not cover. HPV can be transmitted not only through penetrative sex but also through oral sex or genital-to-genital contact. Engage in mutual monogamy or limit your sexual activity to someone who exclusively engages in sexual activity with you.

    No, girls and women may not need to be screened for cervical cancer before getting vaccinated.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is highly effective in providing protection against HPV.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is a safe and well-tolerated vaccine. It has a favourable safety profile.

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is recommended for routine vaccine in 9-12 years. The maximum age is 26 years if not adequately vaccinated when younger.

    A quadrivalent vaccine protects against 4 types of HPV (human papillomavirus). It is effective against diseases caused by HPV types 6, 11, 16 and 18.

    Available Medicines for

    HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT

    VIEW MORE PRODUCTS